Dr. Bowles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 303-493-7000
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2009 - 2012- University of ColoradoResidency, Internal Medicine, 2005 - 2008
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2005
Certifications & Licensure
CO State Medical License 2007 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
- Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 471 citationsDevelopment and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICO...Brian O'Sullivan, Shao Hui Huang, Jie Su, Adam S. Garden, Erich M. Sturgis
The Lancet. Oncology. 2016-04-01 - 17 citationsPhase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).Alan L Ho, Nathan R Foster, Alex J Zoroufy, Jordan D Campbell, Francis Worden
Journal of Clinical Oncology. 2022-12-20 - 81 citationsComprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.J.S. Ross, Kai Wang, Jo-Anne Vergilio, James Suh, Shakti H. Ramkissoon
Annals of Oncology. 2016-10-01
Journal Articles
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerHilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
Press Mentions
Hope for Chemo Brain: Cannabis Could Improve Sleep and Cognitive Function in Cancer PatientsApril 28th, 2023
Largest-Ever Study of Thyroid Cancer Genetics Finds New Mutations, Suggests ImmunotherapyApril 26th, 2018
Largest-Ever Study of Thyroid Cancer Genetics Finds New Mutations, Suggests ImmunotherapyApril 26th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
